Seeing Is Believing
Currently out of the existing stock ratings of Daniel Arias, 125 are a BUY (66.84%), 62 are a HOLD (33.16%).
Analyst Daniel Arias, currently employed at STIFEL, carries an average stock price target met ratio of 58.09% that have a potential upside of 18.75% achieved within 141 days.
Daniel Arias’s has documented 354 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on GH, Guardant Health at 24-Sep-2025.
Analyst best performing recommendations are on TEM (TEMPUS AI, COMMON STOCK).
The best stock recommendation documented was for TEM (TEMPUS AI, COMMON STOCK) at 11/11/2024. The price target of $65 was fulfilled within 3 days with a profit of $12.62 (16.26%) receiving and performance score of 54.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$140
$3.38 (2.47%)
$130
5 days ago
(07-Oct-2025)
6/6 (100%)
$1.44 (1.04%)
38
Hold
$150
$13.38 (9.79%)
$125
10 days ago
(02-Oct-2025)
14/16 (87.5%)
$11.3 (8.15%)
119
Buy
$150
$13.38 (9.79%)
$116
27 days ago
(15-Sep-2025)
15/20 (75%)
$24.62 (19.64%)
366
Buy
$155
$18.38 (13.45%)
$165
4 months 13 days ago
(29-May-2025)
7/10 (70%)
$42.18 (37.39%)
278
Hold
$150
$13.38 (9.79%)
$147
9 months 29 days ago
(12-Dec-2024)
8/8 (100%)
$12.12 (8.79%)
99
Which stock is Daniel Arias is most bullish on?
Which stock is Daniel Arias is most reserved on?
What Year was the first public recommendation made by Daniel Arias?